3D Systems Enables First FDA Clearance for Implant from a Point-of-Care Institution

<p>ROCK HILL, S.C., July 28, 2026 (GLOBE NEWSWIRE) -- Today, <a href="https://www.globenewswire.com/Tracker?data=bVRCCi2wwfXILmHbFmIAkIfEJxgbQ91WqGG_KPbOhUid4FNuFMwn5oJNIDceL-dStx3J1l62swY2bzb5E7EpZDe66A51ukYoW-3WNaAv8c7W_ZtT2Hvw8bvihglNviv7m_i4tqNsY3ODL0B52EjKVxzFFpfkNOmd9miZRw680MnLYBwngbW_z4m02PgNCkA4kAw0EdUUbDXnHzxV5TpDjwtdZ68asOz0wCKEJ3NdvyfQNeeper-QtKAnPxkCMjeHW7LDvi3QrZpsDEPktN6ebA==" rel="nofollow" target="_blank" title="3D Systems">3D Systems</a> (NYSE: DDD) announced its role in enabling the Defense Health Agency (DHA) and the Walter Reed National Military Medical Center’s 3D Medical Applications Center (3D MAC) to achieve U.S. Food and Drug Administration (FDA) premarket clearance for the 3D MAC Titanium Cranial Plate (TCP) System, the first-ever FDA-cleared implant granted to a point-of-care institution. 3D MAC's patient-specific Titanium Cranial Plate (TCP) will be used to treat U.S. active duty personnel and war fighters suffering from traumatic head injuries around the world.</p>